series-a
Stage
2020
Founded
2
Investors
About
Tetra Therapeutics (formerly Tetra Discovery Partners) was a discovery-based biopharmaceutical company focused on developing treatments for neurodevelopmental disorders such as Fragile X syndrome. The company and its clinical programs were acquired by Shionogi in 2020 and are now managed by Shionogi Inc.
Explore Tetra Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.